1. Dasbiswas Arup
2. Dasbiswas Debasri
3. Malhi Harshveer Singh

9789354653933

10.5005/jp/books/18566_67

1/e

2022

5

1. ICVS; ICVS, IPGME & R, Kolkata; DNBE (Cardio), RTIICS, Kolkata, West Bengal, India, Nil Ratan Sircar (NRS) Medical College, Kolkata, West Bengal, India, Institute of Cardiovascular Sciences; ICVS, IGPMER and SSKM Hospital, Kolkata, West Bengal, India; National CSI, Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, West Bengal, India, DNBE (CCARDIO); Rabindranath Tagore International, Institute of Cardiac Sciences, Kolkata, West Bengal, India, DNBE (Cardio), RTIICS, Kolkata; Institute of Postgraduate Medical Education and Research (IPGME&R) and Seth Sukhlal Karnani Memorial (SSKM) Hospital, Kolkata; ICVS, IPGME&R, Kolkata, West Bengal, India, SSKM Hospital and Institute of Postgraduate Medical Education and Research (IPGMER), Kolkata, West Bengal, India
2. Calcutta National Medical College, Kolkata, West Bengal, India
3. Allergopharma, Merck Specialities Private Limited, Mumbai, Maharashtra, India, Biopharma l Medical Affairs, Merck Specialities Private Limited, Mumbai, Maharashtra, India, Medical Affairs CM Care, Mumbai, Maharashtra, India

Acute coronary syndrome, ACS, unstable angina, UA, ST-segment elevation myocardial infarction, STEMI, vulnerable plaque, plaque passivation, tumor necrotic factor, clinical evidence, chronic coronary syndrome